|
|
|
|
— |
solving_gaps_in_blood_p_essu_e_monito_ing [2025/09/11 14:31] (current)
rosariamzp created |
| | (Image: [[https://www.medsource-sw.com/images/products/mna-121-002162-00.png?timestamp=1669843807|https://www.medsource-sw.com/images/products/mna-121-002162-00.png?timestamp=1669843807]]) |
| | AlertWatchTM’s decision help software has been used as a technical assist to supply an alert to blood stress measurement gaps. Although used routinely, the potential effectiveness of this alert to reduce blood strain gaps has not yet been studied. APSF coverage is not to print names of some medical software program devices as a result of it may very well be construed as endorsing that product. I read with curiosity the letter within the Rapid Response column (APSF Newsletter June 2019) concerning questions about gaps in blood pressure monitoring from Dr. Sheron McLean, a faculty member in our department.1 I am familiar with the issue of blood strain monitoring gaps, [[https://wiki.apeconsulting.co.uk/index.php/Valuable_Prognostic_Info_Provided_By_24-h_Ambulatory_Blood_Pressure_Monitoring_Past_The_Blood_Pressure_Level|BloodVitals SPO2]] since our multi-institutional examine assessing the power to scale back the incidence of those gaps by using both visual alerts, audible and visible alerts, or no alerts.2 The research showed that audible alerts did scale back monitoring gaps however the visible alerts alone didn't.2 Subsequently, we found that blood strain monitoring gaps are a possible patient security concern since they had been associated with an increased incidence of hypotension.Three Based upon this research, we developed, and have been utilizing, a choice support system with visual and audible alerts that may be programmed for customized alerts. |
| | |
| | |
| | [[https://www.youtube.com/embed/D0ayF9Kza9E?modestbranding=1&rel=0&color=white|external page]] |
| | This system (AlertWatch™ Ann Arbor, MI), was commercialized and cleared by the Food and Drug Administration (FDA) as a medical software gadget. The name of our firm was not indicated in Dr. McLean’s letter apparently as a result of it was removed during the editing course of "to keep away from any appearance of endorsement by APSF."4 The response from General Electric (GE) revealed in depth textual content and multiple screenshots describing how they try to approach this drawback. This text may very well be seen as an endorsement for the GE CARESCAPE B-850 monitor. Within the spirit of informing anesthesia professionals about methods for enhancing patient security, I am stunned the Anesthesia Patient Safety Foundation would not reference a system meant to reinforce safety, especially in the context of a complete challenge on alarm fatigue and affected person security. APSF ought to publish the editorial coverage on content referencing a business product to facilitate communication to the anesthesia neighborhood yet avoid the potential perception of "endorsing" a particular product, BloodVitals SPO2 sponsor, or APSF donor. |
| | |
| | |
| | |
| | Kevin Tremper is the Robert B. Sweet Professor [[https://git.koppa.pro/arturomiley778|BloodVitals SPO2]] and chair of the Department of Anesthesiology, University of Michigan. He can also be the founder and [[http://dogetransparency.wiki/index.php/User:Eddie09J11|BloodVitals SPO2]] equity holder in AlertWatch. 1. McLean S. Dear Rapid Response: Monitoring gaps. 2. Ehrenfeld JM, Epstein RH, Bader S, [[https://git-i.ir/antjealbright|BloodVitals SPO2]] et al. Automatic notifications mediated by anesthesia info administration systems reduce the frequency of prolonged gaps in blood stress documentation. 3. Kruger GH, Shanks A, Kheterpal S, et al. Influence on non-invasive blood strain measurement intervals on the incidence of intraoperative hypotension. J Clin Monit Comput. We want to thank you to your interest within the APSF and understand the concern you may have raised in your current letter. The letter from Dr. McLean was submitted to our Rapid Response (formerly Dear SIRS) column. The history of that column is to obtain feedback, typically disparaging, about expertise utilized in affected person care, and publish these comments with the chance for a company response from the vendor. |
| | |
| | |
| | |
| | The goal of the column is to offer a forum to bring affected person security concerns about expertise to gentle while allowing the design work by the corporate to be clarified, and also to focus on any consumer points that will have contributed to an issue. Not infrequently, the recognized security concern influences the product design course of by the companies and leads to product improvement and/or helps to teach professionals about the proper use of the device. Over time, this column has been very impactful partially as a result of we have labored laborious to handle the corporate sensitivities. Within the editorial process, we're cognizant of the potential impact if the APSF Newsletter is used as a platform to advertise or disparage any specific vendor or technology. On this particular case, we centered on the idea of blood pressure measurement as a potential affected person security concern and thanks to Dr. McLean, the concept is explored properly within the APSF Newsletter. Not solely was her letter essential of the GE design, but given the truth that AlertWatch™ originated in your division, we have been involved that by mentioning the product by identify, her letter can be viewed as an endorsement that may very well be referenced and used to advertise the product. Undoubtedly, you can admire the editorial challenges to managing the content material in a trend that informs the readers and gives a discussion board for firms to spotlight the design process but is impartial with regard to any corporate interests. Ideally, we'd publish an editorial coverage that clearly signifies the threshold for mentioning a particular company, however finally, the editorial course of turns into a matter of judgement. Suffice it to say that the editorial coverage is driven to offer a forum for bringing patient safety issues to light with out particularly endorsing a selected product or vendor. |
| |
